Skip to main content
Top
Literature
1.
go back to reference De Innocentiis C, Ricci F, Khanji MY, Aung N, Tana C, Verrengia E, et al. Athlete’s heart: diagnostic challenges and future perspectives. Sports Med. 2018;48(11):2463–77.CrossRefPubMed De Innocentiis C, Ricci F, Khanji MY, Aung N, Tana C, Verrengia E, et al. Athlete’s heart: diagnostic challenges and future perspectives. Sports Med. 2018;48(11):2463–77.CrossRefPubMed
2.
go back to reference Sofi F, Capalbo A, Pucci N, Giuliattini J, Condino F, Alessandri F, et al. Cardiovascular evaluation, including resting and exercise electrocardiography, before participation in competitive sports: cross sectional study. BMJ. 2008;337:a346.CrossRefPubMed Sofi F, Capalbo A, Pucci N, Giuliattini J, Condino F, Alessandri F, et al. Cardiovascular evaluation, including resting and exercise electrocardiography, before participation in competitive sports: cross sectional study. BMJ. 2008;337:a346.CrossRefPubMed
3.
go back to reference Claessen G, Schnell F, Bogaert J, Claeys M, Pattyn N, De Buck F, et al. Exercise cardiac magnetic resonance to differentiate athlete’s heart from structural heart disease. Eur Heart J Cardiovasc Imaging. 2018;19(9):1062–70.CrossRefPubMed Claessen G, Schnell F, Bogaert J, Claeys M, Pattyn N, De Buck F, et al. Exercise cardiac magnetic resonance to differentiate athlete’s heart from structural heart disease. Eur Heart J Cardiovasc Imaging. 2018;19(9):1062–70.CrossRefPubMed
4.
go back to reference Maron BJ, Pelliccia A, Spirito P. Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete’s heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation. 1995;91(5):1596–601.CrossRefPubMed Maron BJ, Pelliccia A, Spirito P. Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete’s heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation. 1995;91(5):1596–601.CrossRefPubMed
5.
go back to reference La Gerche A, Baggish A, Heidbuchel H, Levine BD, Rakhit D. What may the future hold for sports cardiology? Heart Lung Circ. 2018;27(9):1116–20.CrossRefPubMed La Gerche A, Baggish A, Heidbuchel H, Levine BD, Rakhit D. What may the future hold for sports cardiology? Heart Lung Circ. 2018;27(9):1116–20.CrossRefPubMed
6.
go back to reference Dickhuth HH, Röcker K, Hipp A, Heitkamp HC, Keul J. Echocardiographic findings in endurance athletes with hypertrophic non-obstructive cardiomyopathy (HNCM) compared to non-athletes with HNCM and to physiological hypertrophy (athlete’s heart). Int J Sports Med. 1994;15(5):273–7.CrossRefPubMed Dickhuth HH, Röcker K, Hipp A, Heitkamp HC, Keul J. Echocardiographic findings in endurance athletes with hypertrophic non-obstructive cardiomyopathy (HNCM) compared to non-athletes with HNCM and to physiological hypertrophy (athlete’s heart). Int J Sports Med. 1994;15(5):273–7.CrossRefPubMed
7.
go back to reference Morganroth J, Maron BJ, Henry WL, Epstein SE. Comparative left ventricular dimensions in trained athletes. Ann Intern Med. 1975;82(4):521–4.CrossRefPubMed Morganroth J, Maron BJ, Henry WL, Epstein SE. Comparative left ventricular dimensions in trained athletes. Ann Intern Med. 1975;82(4):521–4.CrossRefPubMed
8.
go back to reference Baggish AL, Weiner RB, Kanayama G, Hudson JI, Lu MT, Hoffmann U, et al. Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation. 2017;135(21):1991–2002.CrossRefPubMedPubMedCentral Baggish AL, Weiner RB, Kanayama G, Hudson JI, Lu MT, Hoffmann U, et al. Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation. 2017;135(21):1991–2002.CrossRefPubMedPubMedCentral
9.
go back to reference Karila TA, Karjalainen JE, Mäntysaari MJ, Viitasalo MT, Seppälä TA. Anabolic androgenic steroids produce dose-dependant increase in left ventricular mass in power athletes, and this effect is potentiated by concomitant use of growth hormone. Int J Sports Med. 2003;24(5):337–43.CrossRefPubMed Karila TA, Karjalainen JE, Mäntysaari MJ, Viitasalo MT, Seppälä TA. Anabolic androgenic steroids produce dose-dependant increase in left ventricular mass in power athletes, and this effect is potentiated by concomitant use of growth hormone. Int J Sports Med. 2003;24(5):337–43.CrossRefPubMed
10.
go back to reference De Piccoli B, Giada F, Benettin A, Sartori F, Piccolo E. Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function. Int J Sports Med. 1991;12(4):408–12.CrossRefPubMed De Piccoli B, Giada F, Benettin A, Sartori F, Piccolo E. Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function. Int J Sports Med. 1991;12(4):408–12.CrossRefPubMed
11.
go back to reference Urhausen A, Hölpes R, Kindermann W. One- and two-dimensional echocardiography in bodybuilders using anabolic steroids. Eur J Appl Physiol Occup Physiol. 1989;58(6):633–40.CrossRefPubMed Urhausen A, Hölpes R, Kindermann W. One- and two-dimensional echocardiography in bodybuilders using anabolic steroids. Eur J Appl Physiol Occup Physiol. 1989;58(6):633–40.CrossRefPubMed
12.
go back to reference Urhausen A, Kindermann W. Sports-specific adaptations and differentiation of the athlete’s heart. Sports Med. 1999;28(4):237–44.CrossRefPubMed Urhausen A, Kindermann W. Sports-specific adaptations and differentiation of the athlete’s heart. Sports Med. 1999;28(4):237–44.CrossRefPubMed
13.
Metadata
Title
Comment on: “Athlete’s Heart: Diagnostic Challenges and Future Perspectives”
Authors
Wilfried Kindermann
Axel Urhausen
Jürgen Scharhag
Publication date
01-03-2019
Publisher
Springer International Publishing
Published in
Sports Medicine / Issue 3/2019
Print ISSN: 0112-1642
Electronic ISSN: 1179-2035
DOI
https://doi.org/10.1007/s40279-018-01043-z

Other articles of this Issue 3/2019

Sports Medicine 3/2019 Go to the issue